A $10 million national grant from Singapore supports a global research collaborative effort targeting the challenges associated with glioblastoma, a highly aggressive and deadly type…
Joel S. Hirschhorn The newest wrinkle on pandemic corruption is how most of the medical and public health establishment refuses to accept natural immunity, obtained…
Chris Martenson’s Fauci takedown videos (episodes 7,8,9) are pretty compelling. Senator Peters has not expressed any interest in asking NIH for the Fauci emails. Now you’d…
At least some contributing Op-Ed authors at TrialSite have considerable concerns involving the exposure of the investigational COVID-19 vaccines to children. Apparently, a growing number of…
The world’s largest global HIV research network has embraced two new monoclonal antibodies as part of the COVID-19 outpatient study sponsored by the National Institutes…
A group of researchers out of Denmark led by Aarhus University Hospital’s infectious disease department conducted a study involving 203 COVID-19 infected patients between the…
Kurome Therapeutics, a preclinical stage company based in Cincinnati, OH, announced the closing of a $15 million Series A financing. The round was co-led by…
Houston, TX- based Stellanova Therapeutics announced the closing of a $15.5 million Series A financing led by Sporos Bioventures, LLC. Proceeds will support development of antibody…
Amyl Therapeutics has closed $22.3 million in Series A financing, led by Belgium-based Noshaq, with participation from Merieux Participations, Sambrinvest, and other private investors. Additionally,…
Cambridge, MA- based Kojin Therapeutics launched with a $60 million Series A led by Polaris Partners, Newpath Partners, and Cathay Health, affiliated to Cathay Capital.…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
